<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04750642</url>
  </required_header>
  <id_info>
    <org_study_id>CLTD5759</org_study_id>
    <nct_id>NCT04750642</nct_id>
  </id_info>
  <brief_title>Cochlear Implant With Dexamethasone Eluting Electrode Array</brief_title>
  <official_title>Cochlear Implant With Dexamethasone Eluting Electrode Array (The CI-DEX Study): Pivotal Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>NAMSA</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Avania</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Vanderbilt University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      An evaluation of Cochlear's cochlear implant electrode array which passively elutes&#xD;
      dexamethasone for a defined period of time to help reduce inflammatory responses.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The primary objectives of the pivotal evaluation is to show the efficacy of the dexamethasone&#xD;
      eluting electrode through reduction in electrode impedances as compared to a standard&#xD;
      electrode and the improvement of speech recognition from preoperative baseline. The secondary&#xD;
      objectives are to assess the benefit-risk balance of a dexamethasone eluting electrode as&#xD;
      similar to a standard electrode by comparison of adverse events and speech outcomes.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">September 2021</start_date>
  <completion_date type="Anticipated">July 2024</completion_date>
  <primary_completion_date type="Anticipated">July 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Comparison of Monopolar (MP1+2) impedance measurement (kOhms) between randomisation groups measured through Custom Sound software during clinical visits.</measure>
    <time_frame>Six months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in speech perception performance (pre-recorded CNC words in quiet in sound booth testing) compared to pre-operative baseline measured during clinical visits.</measure>
    <time_frame>Six months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Comparison of rate and type of device related adverse events between randomisation groups.</measure>
    <time_frame>Six months and twelve months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Comparison of speech perception performance (pre-recorded CNC words in quiet and AzBio sentences in quiet in sound booth testing) between randomisation groups measured during clinical visit.</measure>
    <time_frame>Six months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Sensorineural Hearing Loss</condition>
  <condition>Bilateral Hearing Loss</condition>
  <arm_group>
    <arm_group_label>CI632D Investigational Medical Device (IMD)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>CI632 Comparator Device</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CI632D</intervention_name>
    <description>CI632 cochlear implant with Slim Modiolar electrode including dexamethasone in the electrode within wells (CI632D)</description>
    <arm_group_label>CI632D Investigational Medical Device (IMD)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>CI632</intervention_name>
    <description>CI632 cochlear implant with Slim Modiolar electrode with market approval and does not include dexamethasone</description>
    <arm_group_label>CI632 Comparator Device</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Post-lingual, bilateral, moderate (≥ 40 dB HL) to profound sensorineural hearing loss&#xD;
             at 250, 500and 1000 Hz and profound high-frequency hearing loss, defined by a&#xD;
             pure-tone average (PTA) threshold, 2000 through 8000 Hz, ≥ 90 dB HL.&#xD;
&#xD;
          -  18 years or older at time of consent.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Abnormal cochlear and middle ear anatomy&#xD;
&#xD;
          -  History with cochlear implant surgery&#xD;
&#xD;
          -  Allergy to dexamethasone&#xD;
&#xD;
          -  Women who are pregnant or plan to become pregnant&#xD;
&#xD;
          -  Unable/unwilling to comply to study requirements&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Minal Menezes</last_name>
    <phone>+61459377289</phone>
    <email>mmenezes@cochlear.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Rocky Mountain Ear Centre</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>David Kelsall, Medical Doctor</last_name>
      <phone>3037839220</phone>
    </contact>
  </location>
  <location>
    <facility>
      <name>Fiona Stanley Hospital</name>
      <address>
        <city>Murdoch</city>
        <state>New South Wales</state>
        <zip>6150</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jafri Kuthubutheen, MB BS, MB, FRACS</last_name>
      <phone>+61 8 6152 2222</phone>
      <email>jafri.kuthubutheen@health.wa.gov.au</email>
    </contact>
    <investigator>
      <last_name>Jafri Kuthubutheen, MB BS, MB, FRACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Prince Alfred Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2050</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Catherine Birman, MB BS, FRACS</last_name>
      <phone>+61 2 9515 6111</phone>
      <email>catherine.birman@scic.org.au</email>
    </contact>
    <investigator>
      <last_name>Catherine Birman, MB BS, FRACS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Westmead Hospital</name>
      <address>
        <city>Sydney</city>
        <state>New South Wales</state>
        <zip>2145</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Melville da Cruz, FRANCS, MSc MD</last_name>
      <phone>+61 2 8890 5555</phone>
      <email>melville.dacruz@sydney.edu.au</email>
    </contact>
    <investigator>
      <last_name>Melville da Cruz, FRACS, MSc MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Royal Victorian Eye and Ear Hospital</name>
      <address>
        <city>East Melbourne</city>
        <state>Victoria</state>
        <zip>3002</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Stephen O'Leary, MB BS, MB, FRACS</last_name>
      <phone>+61 03 9929 8666</phone>
      <email>sjoleary@unimelb.edu.au</email>
    </contact>
  </location>
  <location_countries>
    <country>Australia</country>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>January 31, 2021</study_first_submitted>
  <study_first_submitted_qc>February 9, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">February 11, 2021</study_first_posted>
  <last_update_submitted>September 9, 2021</last_update_submitted>
  <last_update_submitted_qc>September 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 10, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cochlear Implant</keyword>
  <keyword>Dexamethasone</keyword>
  <keyword>Bilateral Hearing Loss</keyword>
  <keyword>Sensorineural Hearing Loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Sensorineural</mesh_term>
    <mesh_term>Hearing Loss, Bilateral</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

